Share
Other content recommended for you
- Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study
- Parkinson disease and impulse control disorders: a review of clinical features, pathophysiology and management
- Behavioural and trait changes in parkinsonian patients with impulse control disorder after switching from dopamine agonist to levodopa therapy: results of REIN-PD trial
- Impulse control disorders in Parkinson's disease: decreased striatal dopamine transporter levels
- Sleep and REM sleep behaviour disorder in Parkinson’s disease with impulse control disorder
- Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic
- Extrastriatal dopaminergic changes in Parkinson’s disease patients with impulse control disorders
- ICARUS study: prevalence and clinical features of impulse control disorders in Parkinson’s disease
- Increased risk of impulse control symptoms in Parkinson's disease with REM sleep behaviour disorder
- Initial drug treatment in Parkinson’s disease